Table 6.
Most recent medication/treatment before baseline visits
| n (%) | |||||
|---|---|---|---|---|---|
| All | IGA | Medical institution | |||
| Moderate: IGA = 3 | Severe: IGA = 4 | Hospital | Clinic | ||
| Total | 300 | 220 (100) | 80 (100) | 137 | 162 |
| Any TCS and/or TCI | 260 (86.7) | 194 (88.2) | 66 (82.5) | 117 (85.4) | 143 (87.7) |
| TCS: strongest | 63 (21.0) | 45 (20.5) | 18 (22.5) | 26 (19.0) | 37 (22.7) |
| TCS: very strong | 190 (63.3) | 139 (63.2) | 51 (63.8) | 86 (62.8) | 104 (63.8) |
| TCS: strong | 68 (22.7) | 51 (23.2) | 17 (21.3) | 25 (18.2) | 43 (26.4) |
| TCS: medium | 122 (40.7) | 91 (41.4) | 31 (38.8) | 44 (32.1) | 78 (47.9) |
| TCS: weak | 7 (2.3) | 5 (2.3) | 2 (2.5) | 3 (2.2) | 4 (2.5) |
| TCI | 92 (30.7) | 69 (31.4) | 23 (28.8) | 44 (32.1) | 48 (29.4) |
| Antihistamine drug/anti‐allergic drug | 210 (70.0) | 161 (73.2) | 49 (61.3) | 86 (62.8) | 124 (76.1) |
| Skin moisturizer | 190 (63.3) | 148 (67.3) | 42 (52.5) | 79 (57.7) | 111 (68.1) |
| Skin protectant | 32 (10.7) | 18 (8.2) | 14 (17.5) | 18 (13.1) | 14 (8.6) |
| Oral immunosuppressant | 18 (6.0) | 12 (5.5) | 6 (7.5) | 13 (9.5) | 5 (3.1) |
| Kampo medicines (herbal drug) | 17 (5.7) | 10 (4.5) | 7 (8.8) | 12 (8.8) | 5 (3.1) |
| UV phototherapy | 14 (4.7) | 14 (6.4) | 0 | 4 (2.9) | 10 (6.1) |
| Compound drug (antihistamine + corticosteroid) | 10 (3.3) | 8 (3.6) | 2 (2.5) | 4 (2.9) | 6 (3.7) |
| NSAID | 8 (2.7) | 5 (2.3) | 3 (3.8) | 4 (2.9) | 4 (2.5) |
| Oral corticosteroid | 9 (3.0) | 5 (2.3) | 4 (5.0) | 5 (3.6) | 4 (2.5) |
| Psychotherapy | 0 | 0 | 0 | 0 | 0 |
IGA, Investigator's Global Assessment; NSAID, non‐steroidal anti‐inflammatory drug; TCI, topical calcineurin inhibitor; TCS, topical corticosteroid; UV, ultraviolet.